Ibrutinib was associated with significantly increased risks of both hypertension and atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Caldeira et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: